Qkine Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $1.85M
Latest Deal Amount
  • Investors
  • 8

Qkine General Information

Description

Manufacturer of highly pure bioactive recombinant proteins intended to advance stem cell, organoid, and regenerative medicines. The company's growth factors are built on protein purification and structural biology to tackle challenges in protein production for stem cell biology, thereby enabling researchers to concentrate on essential reagents for the sector.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Sanger Building
  • 80 Tennis Court Road
  • Cambridge CB2 1GA
  • England, United Kingdom
+44 01223 000000

Qkine Timeline

2017201820192020
Date FoundedFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Qkine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 08-Jun-2020 $1.85M 00.000 00.000 Completed Generating Revenue
3. Early Stage VC 01-May-2019 00000 00000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 10-Jan-2019 $25.4K $195K 00000 Completed Generating Revenue
1. Seed Round 23-Apr-2018 $169K $169K 00000 Completed Generating Revenue
To view Qkine’s complete valuation and funding history, request access »

Qkine Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
To view Qkine’s complete cap table history, request access »

Qkine Executive Team (4)

Name Title Board Seat Contact Info
Catherine Elton Ph.D Co-Founder, Chief Executive Officer and Board Member
Marko Hyvonen Ph.D Co-Founder, CSO and Board Member
Tom Mcguire Secretary
David Warwick Chairman
To view Qkine’s complete executive team members history, request access »

Qkine Board Members (6)

Name Representing Role Since
Cassie Doherty Ph.D Parkwalk Advisors Board Member 000 0000
Catherine Elton Ph.D Qkine Co-Founder, Chief Executive Officer and Board Member 000 0000
Christine Martin Cambridge Enterprise Board Member 000 0000
David Warwick Self Chairman 000 0000
Marko Hyvonen Ph.D Qkine Co-Founder, CSO and Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Qkine Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Jonathan Milner Angel (individual) Minority 000 0000 000000 0
Martlet Venture Capital Minority 000 0000 000000 0
Andy Richards Angel (individual) Minority 000 0000 000000 0
O2h Ventures Venture Capital Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »